Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
Canadian Sec - Delayed Quote USD

FLUENT Corp. (FNT-U.CN)

Compare
0.0550
-0.0050
(-8.33%)
At close: February 28 at 2:18:40 PM EST
Loading Chart for FNT-U.CN
DELL
  • Previous Close 0.0600
  • Open 0.0550
  • Bid 0.0550 x --
  • Ask 0.0650 x --
  • Day's Range 0.0550 - 0.0600
  • 52 Week Range 0.0550 - 0.2500
  • Volume 44,656
  • Avg. Volume 111,081
  • Market Cap (intraday) 34.396M
  • Beta (5Y Monthly) 3.01
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0700
  • Earnings Date Apr 28, 2025 - May 2, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

FLUENT Corp., through its subsidiaries, produces and sells medical cannabis in Florida, Pennsylvania, and Texas. The company's medical cannabis products are offered in oral drops, capsules, topicals, syringes, dried flower, pre-rolls, cartridges, concentrates, and edibles under the Fluent brand name. It also sells various third-party branded medical cannabis products. The company was formerly known as Cansortium Inc. and changed its name to FLUENT Corp. in February 2025. FLUENT Corp. was incorporated in 2018 and is headquartered in Tampa, Florida.

getfluent.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: FNT-U.CN

View More

Performance Overview: FNT-U.CN

Trailing total returns as of 2/28/2025, which may include dividends or other distributions. Benchmark is

.

YTD Return

FNT-U.CN
26.67%
S&P/TSX Composite index
3.14%

1-Year Return

FNT-U.CN
71.05%
S&P/TSX Composite index
19.11%

3-Year Return

FNT-U.CN
90.52%
S&P/TSX Composite index
20.31%

5-Year Return

FNT-U.CN
78.00%
S&P/TSX Composite index
51.90%

Compare To: FNT-U.CN

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: FNT-U.CN

View More

Valuation Measures

Annual
As of 2/28/2025
  • Market Cap

    34.40M

  • Enterprise Value

    138.97M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.18

  • Price/Book (mrq)

    8.44

  • Enterprise Value/Revenue

    1.33

  • Enterprise Value/EBITDA

    3.59

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -18.92%

  • Return on Assets (ttm)

    5.23%

  • Return on Equity (ttm)

    -534.24%

  • Revenue (ttm)

    104.19M

  • Net Income Avi to Common (ttm)

    -19.71M

  • Diluted EPS (ttm)

    -0.0700

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    8.93M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -41.7M

Research Analysis: FNT-U.CN

View More

Company Insights: FNT-U.CN

Research Reports: FNT-U.CN

View More

People Also Watch